title: Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution.
abstract: OBJECTIVE
  Larotaxel is a new taxane compound with poor solubility. The aim of this study is to develop a new formulation to locate the poorly soluble drug and compare the pharmacokinetics and tissue distribution of larotaxel-loaded microsphere (LTX-LM) with the solution form larotaxel-solution (LTX-solution).
  
  
  METHODS
  A sensitive and efficient UPLC-MS/MS method was developed and validated for determination of larotaxel in rat plasma and tissues and applied to assess the plasma protein binding, pharmacokinetics, and tissue distribution.
  
  
  RESULTS
  Pharmacokinetic study indicated that larotaxel plasma disposition was triphasic, and LTX-LM group had markedly higher AUC, smaller clearance, and lower apparent volume of distribution than the LTX-solution group. The tissue distribution exhibited significant lower uptake of LTX-LM in lung, kidney, heart, muscle, and brain among all the tissues, indicating the advantage of LTX-LM over the solution form in reducing drug precipitation in vivo and toxicity in cardiovascular system and central nervous system.
  
  
  CONCLUSIONS
  These results suggest that lipid microsphere could be an effective parenteral carrier for LTX delivery in cancer treatment.
authors: School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenhe District, Shenyang 110016, China.
authors: Zhenzhen
authors: Z
authors: Liu
authors: Yukun
authors: Y
authors: Feng
authors: Lunhui
authors: L
authors: Zhang
authors: Guofei
authors: G
authors: Li
authors: Lulu
authors: L
authors: Geng
authors: Yan
authors: Y
authors: Cui
authors: Fei
authors: F
authors: Teng
authors: Xing
authors: X
authors: Tang
authors: Kaishun
authors: K
authors: Bi
authors: Xiaohui
authors: X
authors: Chen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001798:Blood Proteins / Q000378:metabolism; D002853:Chromatography, Liquid / Q000379:methods*; D004285:Dogs; D005260:Female; D006801:Humans; D008297:Male; D008863:Microspheres; D019999:Pharmaceutical Solutions; D011485:Protein Binding; D051381:Rats; D053719:Tandem Mass Spectrometry / Q000379:methods*; D043823:Taxoids / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014018:Tissue Distribution
chemical_list: D000970:Antineoplastic Agents; D001798:Blood Proteins; D019999:Pharmaceutical Solutions; D043823:Taxoids; C531079:larotaxel